Law Firm Initiates NEW Investigation into Xerox Holdings (XRX) And Encourages Stockholders to Reach Out…..

toner · 2024-11-04T14:52:36-05:00

Bronstein, Gewirtz & Grossman, LLC Launches Investigation into Xerox Holdings Corporation (XRX) and Invites Shareholders to Get in Touch. On October 29, 2024, Xerox announced its financial results for the third quarter of 2024, revealing a non-GAAP earnings per share of $0.25—$0.26 below analysts' expectations. The company reported revenue of $1.53 billion, a year-over-year decline of 7.3%, falling short of consensus estimates by $100 million. Additionally, Xerox disclosed a significant after-tax non-cash goodwill impairment charge of $1.0 billion, equating to $8.16 per share, along with a tax expense charge of $161 million, or $1.29 per share. Following this announcement, Xerox's stock plummeted by $1.79, a decrease of 17.41%, closing at $8.49 per share. Next Steps If you have information relevant to this investigation or purchased Xerox securities, you can contribute by visiting our website at bgandg.com/XRX. For direct inquiries, please reach out to Peretz Bronstein or client relations manager Nathan Miller at Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. No Cost to You We represent investors in class actions on a contingency fee basis, meaning we only seek reimbursement for expenses and attorneys' fees if we achieve a successful outcome. Why Choose Bronstein, Gewirtz & Grossman Bronstein, Gewirtz & Grossman, LLC is a well-regarded national firm specializing in securities fraud class actions and shareholder derivative suits. We have successfully recovered hundreds of millions of dollars for investors across the country.Attorney advertising. Past results do not guarantee similar outcomes. Contact Information Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Nathan Miller 332-239-2660 | info@bgandg.com

Tonernews.com, November 4, 2024. USA

This topic is empty.

Viewing 1 post (of 1 total)

Author

Posts
#561149

toner
Keymaster

Bronstein, Gewirtz & Grossman, LLC Launches Investigation into
Xerox Holdings Corporation (XRX) and Invites Shareholders to Get in Touch.
On October 29, 2024, Xerox announced its financial results for the third quarter of 2024, revealing a non-GAAP earnings per share of $0.25—$0.26 below analysts’ expectations. The company reported revenue of $1.53 billion, a year-over-year decline of 7.3%, falling short of consensus estimates by $100 million. Additionally, Xerox disclosed a significant after-tax non-cash goodwill impairment charge of $1.0 billion, equating to $8.16 per share, along with a tax expense charge of $161 million, or $1.29 per share. Following this announcement, Xerox’s stock plummeted by $1.79, a decrease of 17.41%, closing at $8.49 per share.

Next Steps
If you have information relevant to this investigation or purchased Xerox securities, you can contribute by visiting our website at bgandg.com/XRX. For direct inquiries, please reach out to Peretz Bronstein or client relations manager Nathan Miller at Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.

No Cost to You
We represent investors in class actions on a contingency fee basis, meaning we only seek reimbursement for expenses and attorneys’ fees if we achieve a successful outcome.

Why Choose Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a well-regarded national firm specializing in securities fraud class actions and shareholder derivative suits. We have successfully recovered hundreds of millions of dollars for investors across the country.Attorney advertising. Past results do not guarantee similar outcomes.

Contact Information
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
Author

November 4, 2024 at 2:52 PM

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.

The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty, or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action based on the content on our site.